References
- Tarsy D. Neuroleptic-induced extrapyramidal reactions: Classification, description and diagnosis. Clin Neuropharmacol 1983; 6: S9–S26
- Meltzer H. Y., Matsubara S., Lee JC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2-and serotonin pK1 values. J Pharmacol Exp Ther 1989; 25: 238–246
- Anon: Seroquel: A putative atypical antipsychotic drug with serotonin- and dopamine-receptor antagonist properties: preclinical and early clinical trials in schizophrenia. J Clin Psychiatry 1995; 56: 438–445
- Casey D. Clozapine: Neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 1989; 99: S47–S53
- Claghorn J., Honigfeld G., Abuzzahab F. S., Wang R., Steinbook A., Tuason V., Klerman G. The risks and benefits of clozapine vs chlorpromazine. J Gin Psychopharmacol 1987; 7: 377–384
- Shopsin B., Klein H., Aaronson M., Collora M. Clozapine, chlorpromazine and placebo in newly hospitalized, acutely schizophrenic patients: A controlled, double-blind comparison. Arch Gen Psychiatry 1979; 36: 657–664
- Borison R. L., Arvanitis L. A., Miller BG. ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. J Clin Psychopharmacol 1996; 16: 158–169
- Sailer C. F., Salama AI. Seroquel: Biochemical profile of a potential atypical antipsychotic. Psychopharmacology 1993; 112: 285–292
- Griffith R. W., Saameli K. Clozapine and agranulocytosis. Lancet 1975; 2: 657
- Grohmann R., Ruther E., Sassim N., Schmidt LG. Adverse effects of clozapine. Psychopharmacology 1989; 99: S101–S104
- Seroquel: Product Information: Zeneca Pharmaceuticals 1997
- Goldstein J. M., Litwin L. C., Sutton E. B., Malick JB. Seroquel: Electrophysical profile of a potential atypical antipsychotic. Psychopharmacology 1993; 112: 293–298
- Richelson E. Preclinical pharmacology of neuroleptics. Focus on new generation compounds. J Clin Psychiatry 1996; 57: 4–11, suppl 11
- Mady S., Wax P., Wang D. Pediatric clozapine intoxication. Am J Emerg Med 1996; 14: 462–463
- Fabre LF, Jr., Arvanitis L., Pultz J. ICI 204,636, a novel, atypical antipsychotic: Early indication of safety and efficay in patients with chronic and sub-chronic schizophrenia. Oin Ther 1995; 17: 366–378
- Ereshefsky L. Pharmacokinetics and drug interactions: Update for new antipsychotics. J Clin Psychiatry 1996; 57: 12–25, suppl 11